Clinical Trials Directory

Trials / Completed

CompletedNCT00000288

Role of Metabolites in Nicotine Dependence (2) - 5

Role of Metabolites in Nicotine Dependence (2)

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
0 (planned)
Sponsor
National Institute on Drug Abuse (NIDA) · NIH
Sex
All
Age
21 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the effects of varying doses of cotinine on cigarette self-administration.

Detailed description

Previous studies have shown that cotinine, a metabolite of nicotine, antagonizes some of the effects of nicotine. One study showed that nicotine eliminates some of the beneficial effects of the nicotine patch in reducing withdrawal symptoms. The purpose of this study was to examine the effects of cotinine. The results generally showed no effects on self-administration of cigarettes, although higher serum nicotine levels were observed on the highest doses of cotinine compared to placebo or lower doses of cotinine.

Conditions

Interventions

TypeNameDescription
DRUGCotinine fumarate

Timeline

Start date
1995-12-01
Completion
2002-12-01
First posted
1999-09-21
Last updated
2017-01-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00000288. Inclusion in this directory is not an endorsement.